1Vail DM,Amantea MA,Colbern GT,et al.Pegylated liposomal doxorubicin:proof of principle using preclinical animal models and pharmacokinetic studies [J].Semin Oncol.2004,31 (6Suppl 13):16-35.
2Osoba D,Northfelt DW,Budd DW,et al.Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS) -related Kaposi's sarcoma:a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin,bleomycin,and vincristine [J].Cancer Invest.2001,19 (6):573-580.
3Bafaloukos D,Papadimitriou C,Linardou H,et al.Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcima:a phase Ⅱ study of the Hellenic Cooperative Oncology Group [J].Br J Cancer,2004,91(9):1639-1644.
4Judson I,Radford JA,Harris JY,et al.Randomised phase Ⅱ trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma:a study by the ECORTC Soft Tissue and Bone Sarcoma Group[J].Eur J Cancer,2001,37(7):870-877.
10Moretti G,Guimaraes R,Oliveira KM,et al.Rhabdomyosar-coma of the head and neck:24 cases and literature review[J].Braz J Otorhinolaryngol,2010,76(4):533-537.
